Facial Injectable Market Overview

The global facial injectable market is predicted to touch USD 29,649.7 million at a 28.1% CAGR over the forecast period (2018-2025), as per the new Market Research Future (MRFR) report. Facial injectable or dermal fillers are products that help in facial transformation. They are basically face skin fillers that are used in different applications. Scars treatment, acne treatment, wrinkle removal, enhancement of lips, skin smoothening, and reduction in skin folds, are some of the common uses of facial injectables. Facial injectables are highly favored for its wonderful benefits such as instant results, no downtime, long-lasting effects, natural and subtle results, beneficial for the skin, improve self-confidence, and also boost collagen levels. 

Additionally, health factors such as the rise in obesity and accidents create a substantial demand in the facial injectable market. Increased safety margins that the advanced treatment offers alongside, the growing numbers of facial rejuvenating hospitals, impact the market growth, positively. Some financing agencies, alongside, cosmetic surgeons and other medical practitioners, provide injectable facial procedures with easy financing plans; this factor also adds on to the growth of the market.

Various factors are propelling the facial injectable market growth. These factors, as per the new MRFR report, include burgeoning demand for dermal fillers treatment, advancements in bio-engineering technologies and facial rejuvenation, cultural and social factors such as the influence of film, fashion, and media industry, changing dimensions of beauty, and peer pressure for beauty and appearance. Additional factors pushing market growth include the rise in accidents and obesity, increased safety margins offered by advanced treatments, rising aesthetic standards, growing urban population, growing demand from middle-age population, and increase in the number of hospitals offering facial rejuvenating services. 

Key Players

Leading players profiled in the facial injectable market report include Scivision Biotech Inc., Sinclair, Suneva Medical, Sanofi, Valeant Pharmaceuticals, Integra Lifesciences, Merz Pharma, Allergan, Galderma, and others. 

Facial injectable Market Segmentation

The report is segmented into four market dynamics to widen the scope of understanding,

• By Type: Botulinum Toxin, Hyaluronic Acid, Polymers Particles, Calcium Hydroxylapatite, Poly-l-Lactic Acid, Polymethylmethacrylate, and Collagen, among others.
• By Application: Facial Line Correction Treatment, Face-Lift, and Lip treatments, among others.
• By End-user : Hospitals, Specialty Clinics, and Spa Beauty Clinic, among others.
• By Regions: Europe, North America, APAC, and the Rest-of-the-World.

Highly competitive, the global facial injectable market appears to be fragmented characterized by the presence of several well-established players. Players are also focusing on product launches and expanding their global footprints by entering untapped markets. They also focus on optimizing situational awareness for customers to ensure their mission success. To gain a bigger share in this market, these players incorporate strategic initiatives such as mergers acquisition, collaboration, and innovation.

They substantially invest in RD activities to develop the cost-competitive product portfolio. These players also invest in building state-of-the-art laboratories and strong sales distribution network, that can help them to gain leadership in the market. A growing emphasis has been observed among dental industry marketers on inbound lead generation over branding-oriented efforts.

Facial injectable Market Regional Analysis

By region, the facial injectable market report covers the latest trends and growth opportunities across Europe, North America, the Asia Pacific (APAC), and the Rest of the World.

Of these, North America will lead the market over the forecast period. Factors aiding growth in the region include the presence of an enormous aesthetician population, an increase in cosmetic procedure spending, rising approvals of facial injectable products, growing prominence regarding physical appearance, and increasing consciousness regarding forward-looking beauty treatments. Canada and the US are the leading contributors in the market chiefly due to the presence of a massive geriatric population, high living standards, and high healthcare expenses. 

The facial injectable market in Europe is predicted to have the second-largest share in the market over the forecast period. Factors aiding growth in the region include the resurging economy in the region, access to a quality life, growing consumer purchasing power, presence of a well-established healthcare sector, and vast aesthetician populace. Germany and France are the leading contributors in the region chiefly due to Germany having the largest medical device market, increasing number of people opting for facial aesthetics treatments, and growing investment in facial injectables. 

The facial injectable market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include increasing beauty concerns among the elderly and mid-age population, growing media and entertainment industry in Korea, China, and India, and flourishing medical tourism in Malaysia, Thailand, and Vietnam. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]